Postoperative Identification of Tumor Cells At the Lumpectomy Site of Patients with Early Breast Cancer

You may be eligible if

• 1. Women with pathologic stage I to IIB invasive mammary breast cancer.
• 2. Tumor size over 1 cm.
• 3. Patient age 50 years or younger.
• 4. Primary tumor non-lobular.
• 5. Primary tumor non-low grade or Oncotype DX score \> 18.
• 6. Patient is six weeks or earlier post-lumpectomy.
• 7. Seroma is clinically palpable and symptomatic causing discomfort and/or swelling of the lumpectomy site OR re-excision of the lumpectomy site is planned.